Oncology Venture reports promising corona data for own drug candidate
Biotech firm Oncology Venture just received promising initial data for its drug candidate against ovarian cancer, which the company is testing as a potential treatment for Covid-19. The company's stock soars.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY IDA JACOBSEN
Four months after biotech company Oncology Venture joined the race to firstly provide a treatment for Covid-19, the Danish-based company is ready with its initial data.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
